CytomX shares fall on portfolio reshuffle (CTMX:NASDAQ)


Cut unnecessary expenses.

Andrii Yalanskyi

Shares of CytomX Therapeutics (NASDAQ:CTMX) fell on Tuesday after the cancer drug developer announced a roughly 40% reduction in its workforce as part of a portfolio reorganization drive aimed at cost savings.

Citing plans to allocate resources to the maximum



Source link

  • Related Posts

    Consumer prices in China are barely rising as deflationary pressures weigh in

    Stay informed with free updates Just sign up to China’s economy myFT Digest — delivered directly to your inbox. Chinese consumer prices barely rose in December, underscoring deflationary pressures in…

    Bonds flashing red, 10-year “term premium”.

    A look at the day ahead in the US and global markets by Mike Dolan Dragging up government borrowing costs around the world, the New Year’s uptick in long-term US…

    Leave a Reply

    Your email address will not be published. Required fields are marked *